Related Experiment Video
Updated: Feb 8, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas
Shai Rosenberg1,2, Iva Simeonova1, Franck Bielle1,3
1Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM, F-75013, Paris, France.
Abstract:
Chordoid glioma (ChG) is a characteristic, slow growing, and well-circumscribed diencephalic tumor, whose mutational landscape is unknown. Here we report the analysis of 16 ChG by whole-exome and RNA-sequencing. We found that 15 ChG harbor the same PRKCA D463H mutation. PRKCA encodes the Protein kinase C (PKC) isozyme alpha (PKCα) and is mutated in a wide range of human cancers. However the hot spot PRKCA D463H mutation was not described in other tumors. PRKCA D463H is strongly associated with the activation of protein translation initiation (EIF2) pathway. PKCαD463H mRNA levels are more abundant than wild-type PKCα transcripts, while PKCαD463H is less stable than the PCKαWT protein. Compared to PCKαWT, the PKCαD463H protein is depleted from the cell membrane. The PKCαD463H mutant enhances proliferation of astrocytes and tanycytes, the cells of origin of ChG. In conclusion, our study identifies the hallmark mutation for chordoid gliomas and provides mechanistic insights on ChG oncogenesis.
Insights
Researchers identified a specific mutation in Protein kinase C alpha (PKCα) as a hallmark of chordoid glioma. This PRKCAD463H mutation drives tumor growth by affecting protein translation and cell membrane interactions.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Genomics
Background:
- Chordoid glioma (ChG) is a rare, slow-growing diencephalic tumor.
- The genetic underpinnings of ChG have remained largely unknown.
Purpose of the Study:
- To elucidate the mutational landscape of chordoid glioma.
- To identify key molecular drivers of ChG oncogenesis.
Main Methods:
- Whole-exome sequencing of 16 ChG samples.
- RNA-sequencing to analyze gene expression and mutations.
Main Results:
- A recurrent PRKCAD463H mutation was identified in 15 out of 16 ChG tumors.
- This mutation activates the EIF2 protein translation initiation pathway.
- The mutant PKCα protein is less stable and depleted from the cell membrane, enhancing astrocyte and tanycyte proliferation.
Conclusions:
- The PRKCAD463H mutation is the hallmark genetic alteration in chordoid glioma.
- This discovery provides critical mechanistic insights into ChG development and potential therapeutic targets.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Point and Frameshift Mutations
Mutations in Microorganisms

